Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0000950170-23-022775 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2023-05-17 | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Off | M - OptEx | $5.68 | +12.0K | 220.4K | +6% | +$68.0K |
| DT | 2023-05-17 | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Off | S - Sale+OE | $29.03 | -12.0K | 208.4K | -5% | -$347.3K |
| DMT | 2023-05-17 | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Off | M - OptEx | $0.00 | -12.0K | 15.4K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | M | A | 2,201 | $0.37 | 210,618 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-15 | S | D | 11,965 | $29.03 | 208,417 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2023-05-15 | M | A | 9,764 | $6.88 | 220,382 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2023-05-15 | M | D | 9,764 | $0.00 | 33,770 | D | $6.88 · — to 2031-02-21 | 9,764 Common Stock | (F4) As of the date of this filing, 13,746 shares subject to the option are vested and exercisable. 23,600 shares subject to such option vest and become exercisable in substantially equal monthly installments until December 19, 2023. |
| 5 | Derivative | Stock Option (right to buy) | 2023-05-15 | M | D | 2,201 | $0.00 | 15,404 | D | $0.37 · — to 2029-03-18 | 2,201 Common Stock | (F3) As of the date of this filing, 2,201 shares subject to the option are vested and exercisable. 15,404 shares subject to such option vest and become exercisable in substantially equal monthly installments until November 26, 2023. |